DE60202081D1 - Verfahren zur verbesserten Diagnose von Dysplasien - Google Patents

Verfahren zur verbesserten Diagnose von Dysplasien

Info

Publication number
DE60202081D1
DE60202081D1 DE60202081T DE60202081T DE60202081D1 DE 60202081 D1 DE60202081 D1 DE 60202081D1 DE 60202081 T DE60202081 T DE 60202081T DE 60202081 T DE60202081 T DE 60202081T DE 60202081 D1 DE60202081 D1 DE 60202081D1
Authority
DE
Germany
Prior art keywords
expression
marker
cell
over
dysplastic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60202081T
Other languages
English (en)
Other versions
DE60202081T2 (de
Inventor
Marcus Trunk-Gehmacher
Anja Reichert
Richard Batrla
Ruediger Ridder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche MTM Laboratories AG
Original Assignee
Roche MTM Laboratories AG
Dako Denmark ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche MTM Laboratories AG, Dako Denmark ApS filed Critical Roche MTM Laboratories AG
Application granted granted Critical
Publication of DE60202081D1 publication Critical patent/DE60202081D1/de
Publication of DE60202081T2 publication Critical patent/DE60202081T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Lock And Its Accessories (AREA)
  • Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)
DE60202081T 2002-10-28 2002-10-28 Verfahren zur verbesserten Diagnose von Dysplasien Expired - Lifetime DE60202081T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02024030A EP1416278B1 (de) 2002-10-28 2002-10-28 Verfahren zur verbesserten Diagnose von Dysplasien

Publications (2)

Publication Number Publication Date
DE60202081D1 true DE60202081D1 (de) 2004-12-30
DE60202081T2 DE60202081T2 (de) 2005-12-08

Family

ID=32087956

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60202081T Expired - Lifetime DE60202081T2 (de) 2002-10-28 2002-10-28 Verfahren zur verbesserten Diagnose von Dysplasien

Country Status (5)

Country Link
EP (1) EP1416278B1 (de)
AT (1) ATE283484T1 (de)
DE (1) DE60202081T2 (de)
DK (1) DK1416278T3 (de)
ES (1) ES2231633T3 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109969079A (zh) * 2019-03-05 2019-07-05 天津博顿电子有限公司 一种新能源汽车警示行人的装置

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8060348B2 (en) 2006-08-07 2011-11-15 General Electric Company Systems for analyzing tissue samples
US8131476B2 (en) 2006-08-07 2012-03-06 General Electric Company System and method for co-registering multi-channel images of a tissue micro array
EP2224244A1 (de) * 2009-02-26 2010-09-01 Universität des Saarlandes In-vitro-Diagnoseverfahren oder Assay zur Diagnose der chronischen obstruktiven Lungenerkrankung
WO2012023138A2 (en) 2010-08-18 2012-02-23 Technion Research And Development Foundation Ltd. Volatile organic compounds for detecting cell dysplasia and genetic alterations associated with lung cancer

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109969079A (zh) * 2019-03-05 2019-07-05 天津博顿电子有限公司 一种新能源汽车警示行人的装置
CN109969079B (zh) * 2019-03-05 2022-02-22 天津博顿电子有限公司 一种新能源汽车警示行人的装置

Also Published As

Publication number Publication date
EP1416278A1 (de) 2004-05-06
DE60202081T2 (de) 2005-12-08
EP1416278B1 (de) 2004-11-24
ES2231633T3 (es) 2005-05-16
DK1416278T3 (da) 2005-03-21
ATE283484T1 (de) 2004-12-15

Similar Documents

Publication Publication Date Title
Journe et al. TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome
Gasparini et al. Prognostic determinants in epithelioid sarcoma
ATE364722T1 (de) Verfahren zum nachweis und zur lokalisierung von genen in situ durch hybridisierung einer verzweigten dna
NO20040371L (no) Fremgangsmåte for isolering av mRNA eller cDNA-prober, samt anvendelse derav for fremstilling av et standard diagnostisk gentranskripsjonsmønster og probetestsett og anvendelse av fremgangsmåten for diagnostisering eller identifisering av en sykdom.
MX2010010465A (es) Metodo para la deteccion de igf1r/chr 15 en celulas tumorales circulantes mediante hibridacion fluorescente in situ.
PT1217377E (pt) Processo para a detecção específica de células de tumores e dos seus precursores em colheitas no colo do útero por medição simultânea de pelo menos dois marcadores moleculares diferentes
ATE290210T1 (de) Verwendung von antikörpern gegen embryonales hämoglobin zur identifizierung von fötalen zellen
US20090232740A1 (en) Methods of detecting cancer cells and use of same for diagnosing and monitoring treatment of the disease
ES2767853T3 (es) Detección de la restricción de cadena ligera de inmunoglobulina por hibridación in situ de ARN
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
Bumke et al. Modulation of gene expression by extracellular pH variations in human fibroblasts: a transcriptomic and proteomic study
EP1930445A4 (de) Kit und verfahren zum nachweis von urothelkarzinom
Zou et al. Synchronous screening of multiplexed biomarkers of Alzheimer's disease by a length-encoded aerolysin nanopore-integrated triple-helix molecular switch
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
Xie et al. Dual-channel signals for intracellular mRNA detection via a PRET nanosensor
DE60325541D1 (de) Verfahren/Präparat zur Erkennung von Pankreaskrebs
DE60202081D1 (de) Verfahren zur verbesserten Diagnose von Dysplasien
Mossberg et al. A direct electrochemical detection method of melanoma based on melanoma biomarker
RU2009144277A (ru) Способы и композиции для диагностики остеоартрита у животного семейства кошачьих
CN107937515B (zh) 一种阿尔茨海默的诊疗基因靶点及其应用
CN108034707B (zh) Spag7基因在制备老年痴呆诊断制剂中的应用
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
RU2681501C1 (ru) Способ оценки качества мяса свиней
CA2523466A1 (en) Probes for detection and quantification of lipid second messengers and a method for detecting and quantifying lipid second messengers
WO2020051587A1 (en) Systems and methods for identifying and isolating invasive subpopulations of cancer cells in real-time

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MTM LABORATORIES AG, 69120 HEIDELBERG, DE